Ras/Raf-1/MAPK pathway mediates response to tamoxifen but not chemotherapy in breast cancer patients.


PURPOSE The expression and activation of the Ras/Raf-1/mitogen-activated protein kinase (MAPK) pathway plays an important role in the development and progression of cancer, and may influence response to treatments such as tamoxifen and chemotherapy. In this study we investigated whether the expression and activation of the key components of this pathway… (More)
DOI: 10.1158/1078-0432.CCR-07-4967


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.